Form D · Biotechnology
US Biologic, Inc.
Memphis, TN · CIK 0001719577
Offering snapshot reported Oct 13, 2017 · SEC filing
- Reported sold
- $1M Offering amount: $2M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 29, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2017 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-296626
Source: Form D, filed Oct 13, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mason Kauffman | Director, Executive |
| Thomas Monath | Director |
| Chris Przybyszewski | Director, Executive |
| Michael Shmerling | Director |
| Tommy Thompson | Director |
| David Williams | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
20 Dudley Street Suite 900
Memphis, TN, 38103
Memphis, TN, 38103